If you intend to rely on any legislation referred to on this website, you should access copies of the official versions. These instruments are amended from time to time and may, on occasions, be replaced or new instruments made.

2018 2017 2016 2015 2014 2013 2012 2011

2018

• Therapeutic Goods (Information relating to Shortages and Discontinuations of Supply of Medicines) Specification 2018
  Specifies the kinds of therapeutic goods information that may be released to the public by the Secretary under subsection 61(5C) of the Act, in relation to shortages and discontinuations of the supply of medicines
• Therapeutic Goods Information (Outcomes of Advertising Complaints Investigations) Specification 2018
  Specifies the kinds of therapeutic goods information that the Secretary may release to the public under subsection 61(5C) of the Act regarding advertising complaint outcomes

2017

• Therapeutic Goods Information (Approvals relating to Medicine Shortages) Specification 2017
  Specifies the kinds of therapeutic goods information that may be released to the public by the Secretary. It will facilitate the publication of information relating to approvals granted by the Secretary to address shortages or unavailability of registered medicines.
• Therapeutic Goods Information (Sharing of Committee Information) Specification 2017
  Reflects changes that have been made recently to the Committees established under the Therapeutic Goods Regulations 1990 (the Regulations) to ensure appropriate sharing of Committee information may continue, and to make certain other minor amendments to keep the Specification up- to- date.
• Therapeutic Goods Information (Medical Devices) Specification 2017
  Specifies kinds of therapeutic goods information, relating to medical devises including their chemical and physical properties and possible residues, that may be released by the Secretary under subsection 61(5AA) of the Therapeutic Goods Act 1989
• Medicines Advisory Statements Specification 2017
  Specifies advisory statements that are required to be set out on the label of medicines that are included in a class of medicines prescribed by the regulations
• Therapeutic Goods Information (Sharing information about in-house in vitro diagnostic medical devices) Specification 2017
  Permits the Secretary of the Department of Health to release certain therapeutic goods information that relates to in-house in vitro diagnostic (IVD) medical devices, to NATA, the National Association of Testing Authorities, of Australia
• Therapeutic Goods Information Specification 2017
  Specifies kinds of therapeutic goods information that may be released to the public by the Secretary under subsection 61(5C) of the Therapeutic Goods Act 1989
• Therapeutic Goods (Things that are Biologicals) Specification 2017 (No.1)
  Provides that a thing that comprises or contains live animal cells, tissues or organs is a 'biological' for the purposes of the Therapeutic Goods Act 1989
• Therapeutic Goods Information (Laboratory Testing) Specification 2017
  Specifies kinds of therapeutic goods information, relating to laboratory testing, that may be released to the public by the Secretary under subsection 61(5C) of the Therapeutic Goods Act 1989

2016

• Therapeutic Goods Information (Exemptions from Annual Charges) Specification 2016
  Specifies the kinds of therapeutic goods information that may be released to the public by the Secretary under subsection 61(5C) of the Act

2015

• Therapeutic Goods Information (Sharing of Information about Prescription Medicines) Specification 2015
  Permits the Secretary to release certain kinds of therapeutic goods information to NPS MedicineWise for publication in Australian Prescriber as soon as reasonably possible after its registration in the Australian Register of Therapeutic Goods

2014

• Therapeutic Goods Information (Medicine Shortages Information Initiative) Specification 2014
  Specifies kinds of therapeutic goods information (relating to prescription medicine shortages) that the Secretary may release to the public under subsection 61(5C) of the Act
• Therapeutic Goods Information (Information about Advisory Committee Meetings) Specification 2014
  Specifies kinds of therapeutic goods information that the Secretary may release to the public under subsection 61(5C) of the Act

2013

• Therapeutic Goods Information (Adverse Event Notifications - Medical Devices) Specification 2013
  Specifies the kinds of therapeutic goods information that the Secretary may release to the public under subsection 61(5C) of the Act
• Therapeutic Goods Information (Early Warning System) Specification 2013
  Specifies particular kinds of information that the Secretary may release to the public under subsection 61(5C) of the Act
• Therapeutic Goods Information (Stakeholder Consultation on Database of Adverse Event Notifications - Medical Devices) Specification 2013
  Specifies the kinds of therapeutic goods information, the bodies and kinds of persons to whom the information can be released and the purposes for which it can released by the Secretary under subsection 61(5AA) of the Therapeutic Goods Act 1989
• Therapeutic Goods Information (System for Australian Recall Actions) Specification 2013
  Specifies under subsection 61(5D) of the Therapeutic Goods Act 1989 (the Act) the kinds of therapeutic goods information that the Secretary may release to the public under subsection 61(5C) of the Act. The Specification has the effect of permitting the Secretary to release to the public therapeutic goods information in relation to recall actions being information kept by the TGA in its System for Australian Recall Actions database as set out in Schedule 1 to the Specification
• Therapeutic Goods Information (Stakeholder Consultation on the System for Australian Recall Actions) Specification 2013
  Permits the Secretary to release therapeutic goods information of a kind mentioned in the specification to the persons and bodies mentioned in the Specification, for the purposes set out in the specification

2012

• Therapeutic Goods Information (Joint Adverse Event Notifications System) Specification 2012
  Specifies a number of kinds of therapeutic goods information relating to adverse events in Australia and New Zealand involving medicines, which the Secretary of the Department of Health and Ageing may release to the public under subsection 61(5C) of the Therapeutic Goods Act 1989
• Therapeutic Goods Information (Outcomes of Compliance Reviews of Listed Complementary Medicines) Specification 2012
  Specifies a number of kinds of therapeutic goods information relating to complementary medicines (i.e. medicines listed on the Australian Register of Therapeutic Goods under section 26A of the Act) that the TGA has reviewed for compliance with regulatory requirements applying under the Therapeutic Goods Act 1989
• Therapeutic Goods Information (Database of Adverse Event Notifications) Specification 2012
  Specifies a number of therapeutic goods information relating to adverse events in Australia involving medicines, which the Secretary to the Department of Health and Ageing and delegates of the Secretary may release to the public under subsection 61(5C) of the Act

2011

• Restricted Medicine Specification 2011
  Specifies under subsections 3(2A) & 3(2B) of the Therapeutic Goods Act 1989, medicines or classes of medicine for the purposes of the definition of restricted medicine in subsection 3(1)